Literature DB >> 9266696

The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.

H Wong1, J H Bowie, J A Carver.   

Abstract

Caerin 1.1 is one of the major antimicrobial peptides isolated from the skin of the Australian green tree frog, Litoria splendida. Two-dimensional 1H-1H and 1H-13C NMR spectroscopy in trifluoroethanol/H2O (50:50, by vol.) have been used to assign the 1H and 13C-NMR spectra of this 25-amino-acid peptide. From an examination of these data, and using distance geometry and molecular dynamics calculations, the solution conformation of caerin 1.1 has been determined. The peptide adopts two well-defined helices from Leu2 to Lys11 and from Val17 to His24 separated by a region of less-defined helicity and greater flexibility. Overall, the peptide has a distinct amphipathic charge distribution. The solution structure of caerin 1.1 is compared with activity data against a variety of micro-organisms for the parent peptide and some naturally occurring and synthetic variants of caerin 1.1. The structural and activity data are consistent with caerin 1.1 interacting with membranes in a similar manner to other antimicrobial peptides, i.e. via a carpet-like mechanism whereby the individual peptides aggregate in a helical manner and orient themselves parallel to the membrane in a sheet-like arrangement [Shai, Y. (1995) Trends Biochem. Sci. 20, 460-464].

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266696     DOI: 10.1111/j.1432-1033.1997.00545.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  19 in total

Review 1.  Nonmammalian vertebrate antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

3.  Population trends associated with skin peptide defenses against chytridiomycosis in Australian frogs.

Authors:  Douglas C Woodhams; Louise A Rollins-Smith; Cynthia Carey; Laura Reinert; Michael J Tyler; Ross A Alford
Journal:  Oecologia       Date:  2005-10-04       Impact factor: 3.225

Review 4.  Structural diversity and species distribution of host-defense peptides in frog skin secretions.

Authors:  J Michael Conlon
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

5.  The effect of membrane curvature on the conformation of antimicrobial peptides: implications for binding and the mechanism of action.

Authors:  Rong Chen; Alan E Mark
Journal:  Eur Biophys J       Date:  2011-01-26       Impact factor: 1.733

Review 6.  Genital warts treatment: Beyond imiquimod.

Authors:  Jianwei Yuan; Guoying Ni; Tianfang Wang; Kate Mounsey; Shelley Cavezza; Xuan Pan; Xiaosong Liu
Journal:  Hum Vaccin Immunother       Date:  2018-04-09       Impact factor: 3.452

7.  QCM-D fingerprinting of membrane-active peptides.

Authors:  George A McCubbin; Slavica Praporski; Stefania Piantavigna; Daniel Knappe; Ralf Hoffmann; John H Bowie; Frances Separovic; Lisandra L Martin
Journal:  Eur Biophys J       Date:  2010-12-16       Impact factor: 1.733

8.  Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.

Authors:  G Corzo; P Escoubas; E Villegas; K J Barnham; W He; R S Norton; T Nakajima
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

9.  Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes.

Authors:  M S Balla; J H Bowie; F Separovic
Journal:  Eur Biophys J       Date:  2003-09-10       Impact factor: 1.733

10.  Specific and selective peptide-membrane interactions revealed using quartz crystal microbalance.

Authors:  Adam Mechler; Slavica Praporski; Kiran Atmuri; Martin Boland; Frances Separovic; Lisandra L Martin
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.